Alpha Dna Investment Management LLC Corcept Therapeutics Inc Transaction History
Alpha Dna Investment Management LLC
- $261 Million
- Q3 2024
A detailed history of Alpha Dna Investment Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 10,016 shares of CORT stock, worth $537,158. This represents 0.18% of its overall portfolio holdings.
Number of Shares
10,016Holding current value
$537,158% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$887 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$537 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$443 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$349 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$205 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.74B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...